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Neural plate and sensory placodes share the expression of N-cadherin and Group B1 Sox genes, represented by Sox2. A 219-kb region of
the chicken genome centered by the N-cadherin gene was scanned for neural and placodal enhancers. Random subfragments of 4.5 kb
average length were prepared and inserted into tkEGFP reporter vector to construct a library with threefold coverage of the region. Each clone
was then transfected into N-cadherin-positive (lens, retina and forebrain) or -negative embryonic cells, or electroporated into early chicken
embryos to examine enhancer activity. Enhancers 1–4 active in the CNS/placode derivatives and non-specific Enhancer 5 were identified by
transfection, while electroporation of early embryos confirmed enhancers 2–4 as having activity in the early CNS and/or sensory placodes
but with unique spatiotemporal specificities. Enhancers 2–4 are dependent on SOX-binding sites, and misexpression of Group B1 Sox genes
in the head ectoderm caused ectopic development of placodes expressing N-cadherin, indicating the involvement of Group B1 Sox functions
in N-cadherin regulation. Enhancers 1, 2 and 4 correspond to sequence blocks conserved between the chicken and mammalian genomes, but
enhancers 3 and 5 are unique to the chicken.
D 2005 Elsevier Inc. All rights reserved.Keywords: N-cadherin; Sox2; Group B1 Sox; Enhancers; Genome scan; Electroporation; tkEGFP; Conserved sequenceIntroduction
The primordia of CNS and sensory organs, the neural
plate and sensory placodes, share many features in
common. They start as a thickened epithelial sheet formed
in the ectodermal compartment of the embryo and then
invaginate. A prominent molecule that is commonly
expressed among these tissues and involved in morphoge-
netic cellular actions is N-cadherin. Cells expressing N-
cadherin segregate from bulk ectodermal cells expressing
other cadherins and organize the neural plate and placodes
(Hatta and Takeichi, 1986; Hatta et al., 1987; Takeichi,
1988). It has been demonstrated that interference with N-
cadherin functions affects later histogenesis of the CNS0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.08.005
* Corresponding author. Fax: +81 6 6877 1738.
E-mail address: j61056@hpc.cmc.osaka-u.ac.jp (H. Kondoh).(Bronner-Fraser et al., 1992; Detrick et al., 1990; Fujimori
et al., 1990; Ganzler-Odenthal and Redies, 1998; Matsu-
naga et al., 1988; Radice et al., 1997). Thus, N-cadherin
expression in the sensory placodes and early CNS is
coupled with the morphogenesis of these tissues. However,
regulation of the N-cadherin gene underlying this process
has remained largely uninvestigated.
A set of transcription factor genes expressed in tight
association with the genesis of the early CNS and sensory
placodes is the Group B1 Sox genes, consisting of the
major Sox2 and related Sox3 and Sox1 (Ishii et al., 2001;
Rex et al., 1997; Uchikawa et al., 1999, 2003; Uwanogho
et al., 1995). In early chicken embryos, strong Sox2
expression occurs throughout the neural plate, in sensory
(nasal, lens and otic) placodes and their derivatives and in
branchial arches (Uchikawa et al., 1999, 2003). Not only in
the neural plate (Rex et al., 1997), but also in lens and otic
placodes (Groves and Bronner-Fraser, 2000; Kamachi et al.,286 (2005) 601 – 617
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Sox3 overlap, and later all Group B1 Sox genes (Sox1/2/3)
are expressed in derivatives of these tissue primordia,
neural tube, nasal pit, lens and inner ear (Uchikawa et al.,
1999).
Comparison of the expression pattern of Group B1 Sox
genes with that of N-cadherin indicates a remarkable
resemblance except that N-cadherin expression has meso-
dermal component, somites and heart (Hatta and Takeichi,
1986; Hatta et al., 1987) (see also Fig. 2A). These ob-
servations suggest the possibility that Group B1 SOX
transcription factors are involved in the regulation of N-
cadherin expression.
While keeping the possible involvement of Group B1
Sox functions in the regulation of N-cadherin expression in
mind, we nevertheless took an unbiased systematic
approach to the investigation of N-cadherin regulation.
The N-cadherin gene spans over 200 kb in mammals
(Miyatani et al., 1992), containing 16 exons and a long
intron that occupy half the length of the gene, as is the case
with other cadherin family genes (Hatta et al., 1991).
Among higher vertebrate species, the chicken genome is
more compact than the mammalian genome, and so is the N-
cadherin gene. We successfully identified a single BAC
clone covering from upstream to downstream of the N-
cadherin gene, prepared random subfragments of the BAC
insert and constructed a subfragment library in the tkEGFP
expression vector (Uchikawa et al., 2003), which in total
covers the N-cadherin gene three times. Each clone was
transfected to three representative types of cells expressing
endogenous N-cadherin (lens, retina and forebrain) in
primary cultures, and another set of cells (lung, gizzard
and liver) without N-cadherin expression. One-tenth of the
clones exhibited enhancer activity in a subset of cells, and
mapping of the N-cadherin genomic inserts in these clones
identified five distinct enhancers of separate locations, three
of which were clearly responsible for N-cadherin regulation
in early embryos as demonstrated by embryo electro-
poration. Two of these enhancers are active both in placodes
and the CNS, while another is active only in the placodes in
early embryos. These findings indicate that although N-
cadherin is expressed throughout the placodes and the early
CNS, its regulation depends on regionally and temporarily
specific mechanisms.
Three of the enhancers investigated in this study depend
on a SOX-binding site for their activity, and in the case of
Enhancer 4 the site is bound by Group B1 SOX proteins in
the lens nuclear extract. Furthermore, misexpression of
Group B1 Sox genes in the embryonic head ectoderm
caused ectopic expression of N-cadherin and the develop-
ment of placodal tissue. Collectively, the results obtained
in this study indicate that N-cadherin expression is
regulated by multiple Group B1 SOX-dependent enhancers
in neuro-placodal development and suggest that SOX-
dependent regulation plays a pivotal role in placodal
development.Materials and methods
Identification of a BAC clone carrying the entire chicken
N-cadherin genomic sequence and construction of its
subfragment library
Using the chicken 5V and 3V sequences derived from N-
cadherin cDNA (Hatta and Takeichi, 1986) as probes, a
filter set of chicken genomic BAC clones (Seven Chicken-
HindIII BAC clones, Genefinder Genomic Resources,
Texas A&M University) was screened for clones harboring
both ends of the N-cadherin coding sequence. One of these
clones, pBeloBAC#81-E14, carrying a 219-kb long insert
was positive for both probes and characterized further. The
whole BAC clone DNA was suspended at 0.2 Ag/Al in 100
Al of 10 mM Tris–HCl, 1 mM EDTA and fragmented by
mechanical shearing caused by the pushing and sucking of
the solution through a 27-gauge needle of 19 mm length
attached to a hypodermic syringe 350 times at the rate of 2 s
per cycle, until an average fragment length of 4.5 kb was
attained. The fragments were further size selected by
agarose gel electrophoresis and purified using QIAquick
Gel Extraction Kit (Qiagen). After flushing the sheared
DNA ends using sequential treatment with T4 DNA
polymerase and Klenow’s fragment in the presence of
NTPs and 5V phosphorylation with T4 polynucleotide
kinase, the fragments were inserted by T4 DNA ligase
treatment into EcoRV-cleaved and alkaline phosphatase-
treated ptkEGFP(RV) vector at the insert/vector molar ratio
of 1. ptkEGFP(RV) is a derivative of ptkEGFP (Uchikawa
et al., 2003), in which an EcoRV site is introduced
immediately downstream of the tkEGFP transcriptional
unit. 188 clones were randomly chosen and expanded for
DNA preparation, and DNAs purified using QIA Plasmid
Midi Kit (Qiagen) were used for DNA sequence determi-
nation at both ends of the inserts, and for transfection and
electroporation. Among the 188 clones, 4 carried only BAC
vector sequences, 5 had multiple inserts and the remaining
175 clones identified as single insert clones were used for
further analysis.
Preparation of primary cultures and transfection
Lens epithelial cells were prepared from E14 chicken
embryo and cultured as described previously (Kamachi et
al., 2001). Retinal and forebrain cells of E7 chicken embryo
and gizzard, liver and lung cells of E10 embryos were
dissociated by treatment with 0.25% trypsin in 1 mM EDTA
and cultured in Dulbecco’s modified MEM (Gibco) (Kama-
chi et al., 2001) in 6-well plates by inoculation at 2.4  106
cells per well for retinal and forebrain cells and 105 cells per
well for gizzard, liver and lung cells. After 3 days in culture,
the cells were transfected with 2.2 Ag DNA per well using
Fugene 6 reagent (Roche). 48 h after transfection, EGFP
fluorescence was photo-recorded using a CCD camera
(DP70, Olympus)-equipped epi-fluorescence dissecting
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sity by scraping, suspending and lysing the cells in 300 Al
100 mM potassium phosphate (pH 7.8), 1 mM DTT
containing 1% NP40 and by dispensing 100 Al aliquots
into a 96-well plate and measurement for EGFP fluores-
cence using an LB940 Mithras Multilabel Reader (Berthold
Technologies).
Electrophoretic mobility shift assay (EMSA)
The assay was done using nuclear extracts essentially as
described previously (Kamachi and Kondoh, 1993), em-
ploying polydGdC as non-specific competitors to detect
SOX–DNA complexes.
Electroporation of chicken embryos
Electroporation of chicken embryos in ovo was done
essentially as described previously (Kamachi et al., 2001;
Nakamura et al., 2000). A pair of platinum electrodes was
placed on both sides of the head of a stage 10 chicken
embryo at an interelectrode distance of 4 mm. Plasmid
DNA solution of ca. 1 Al at 2–6 Ag/Al in 10 mM Tris–
HCl at pH 8.0 was delivered to the cathode side of the
head ectoderm and an electric pulse at 5 V/mm for 50 ms
was applied 5 times at 100-ms intervals using an Electro-
porator CUY21 (BEX Co. LTD). Electroporation of the
embryos at stages 4–5 under New’s culture condition
was done as described previously (Uchikawa et al., 2003,
2004).
In situ hybridization and immunohistology
Chicken embryos were staged according to Hamburger
and Hamilton (1951). Whole mount in situ hybridization of
embryos with Sox probes was done as described by
Kamachi et al. (1998). The N-cadherin probe was a 5V
fragment of the cDNA (positions 1–845; DDBJ database
accession number X07277). For immunohistological anal-
ysis, anti-GFP polyclonal rabbit antibodies (CLONTECH),
anti-N-cadherin monoclonal rat antibody (TaKaRa) and
anti-N-CAM monoclonal mouse antibody 5e (Developmen-
tal Studies Hybridoma Bank) were used as the primary
antibodies. Chicken embryo was fixed with 4% paraformal-
dehyde made in PBS-Ca (PBS containing 1 mM CaCl2) for
4 h at 4-C, soaked in 25% sucrose/PBS-Ca and embedded in
OCT compound for preparation of frozen sections. Cross
sections at a thickness of 7 Am were prepared using a cryo-
microtome. The sections were blocked using 2% skim milk
in TBS-Ca (100 mM Tris–HCl at pH 7.5, 150 mM NaCl
and 10 mM CaCl2), reacted with the primary antibodies and
washed with TBS-Ca. For immunofluorescence, the sec-
tions were reacted with Alexa Fluori 488-anti-rabbit IgG
(Molecular Probes) and biotin-conjugated anti-mouse/rat
IgG (Jackson/CAPPEL), then with Alexa Fluori 568-
streptavidin (Molecular Probes).Results
Identification of multiple enhancers regulating N-cadherin
expression in the early CNS and placodes
Using a full-length chicken N-cadherin cDNA (Hatta and
Takeichi, 1986), a chicken genomic BAC library was
screened for a clone carrying both 5V and 3V end sequences,
leading to the identification of pBeloBAC#81-E14. Align-
ment of the cDNA sequence with a partial sequence of the
clone determined by ourselves and with recently published
whole genome data (Hillier et al., 2004) indicated that the
N-cadherin gene of the chicken consists of 16 exons, as in
the case of mammalian N-cadherin gene (Miyatani et al.,
1992), and covers a region of 113.7 kb including the largest
intron 2 of 60 kb. Although gene organization is similar to
mammalian N-cadherin genes, the size of the chicken gene,
including the largest intron, was half that of mammalian
counterparts.
Enhancers regulating N-cadherin expression in the early
CNS and sensory placodes were explored in the 219-kb
insert region of pBeloBAC#81-E14, in which the 43-kb
upstream sequence and the 62-kb downstream sequences are
both included. The total BAC clone DNA was randomly
fragmented by mechanical shearing to an average size of 4.5
kb, flush-ended, and each fragment was inserted in the
tkEGFP(RV) reporter vector to comprise a library which
fully covers the N-cadherin gene region (Fig. 1A). A total of
175 clones derived from single subfragment insertion was
used, which should cover the N-cadherin gene three times.
As these clones were constructed using a tkEGFP reporter
vector (Uchikawa et al., 2003), individual inserts can be
directly tested for their enhancer activities, either by
transfection or by embryo electroporation (Fig. 1A).
We prepared primary cultures of several different cell
types from chicken embryos, three with endogenous N-
cadherin expression and another three without, and trans-
fected them with all individual clones in the library. If
enhancer activity is associated with the insert of a clone,
then activity and specificity of the enhancer can be assessed
by EGFP expression (Figs. 1B and C). EGFP expression
was photo-recorded as a routine (Fig. 1B), but it was also
quantified measuring fluorescence intensity. Lens epithe-
lium of E14 embryo, forebrain of E7 embryo and neural
retina of E7 embryo were used as representative N-cadherin-
expressing cells, while gizzard, lung mesenchyme and liver
of E10 embryo were as those without N-cadherin expression
(Fig. 1B).
Among the 175 clones tested, 23 exhibited enhancer
activity in at least a subset of the cultures, which were
grouped into 4 classes, namely, those showing activity in the
forebrain and retina (8 clones); in the lens, forebrain and
retina (3 clones); in the lens and forebrain (3 clones); and in
all cultures (9 clones).
All inserts were determined for nucleotide sequences at
both ends and positioned in the entire N-cadherin genomic
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(Hillier et al., 2004) (Fig. 1C). This revealed that the inserts
of clones exhibiting enhancer activity of the same cellspecificity class were grouped in the same regions of the N-
cadherin sequence (green lines in Fig. 1C). Those inserts
showing enhancer activity in the forebrain and neural retina
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N-cadherin gene, the intron 1–exon 2 region (group 1) and
in the middle of intron 2 (group 2). The group 3 inserts
showing enhancer activity in the lens, forebrain and neural
retina were mapped to a 3V-proximal region of intron 2,
while group 4 inserts showing activity in the lens and
forebrain were mapped to the short region covering exons
13 and 14. The group 5 inserts active in all cell types were
positioned in a region 3V of the gene. Within a group, the
inserts overlap extensively sharing a common region,
indicating that these groups represent discrete enhancers,
1–5 regulating the N-cadherin gene (Fig. 1C).
Assessment of enhancers using primary tissue cultures
was successful in identifying specific enhancers, but these
cultures were derived from mid-stage embryos. We exam-
ined activity of these specific enhancers in early embryos by
electroporating the tkEGFP-bearing clones in stages 4–5
embryos and observing them at stage 12 (Uchikawa et al.,
2003). An expression pattern of N-cadherin in an embryo at
stage 12 is shown in Fig. 2A. Its comparison with those of
Sox2 and Sox3 indicates a similarity of their expression
patterns (Fig. 2A), except that N-cadherin is also expressed
in the mesodermal tissues, e.g., heart and somites (Hatta and
Takeichi, 1986; Hatta et al., 1987). Strong expression of N-
cadherin in the lens placode is not activated yet and occurs
only after stage 13 (see Fig. 6).
Activity of the enhancers in nasal and lens placode
derivatives was examined by electroporating head surface
ectoderm of stage 10 embryos and following EGFP
expression up to stage 21 (Kamachi et al., 2001). Enhancer
1 was inactive in the assay using early embryo, indicating
that it is active in the brain and neural retina only in the later
stages of development, and was not studied further.
Enhancer 2 was active throughout the CNS at stage 12,
with prominent activity in the anterior CNS up to
rhombomere 1, in rhombomere 6 and remarkably in the
otic placodes (Fig. 2B). Enhancer 2 also showed activity in
the lens placode after stage 13 and in the nasal placode after
stage 14 (Fig. 2C). Enhancer 3 also exhibited enhancer
activity widely throughout the CNS, particularly highly in
rhombomeres 2–6, and in the lens placode (after stage 14)
and nasal placode (after stage 15) (Fig. 2). This enhancer
had no activity in the otic placode, however (Fig. 2B).Fig. 1. Systematic screening of placodal and neural N-cadherin enhancers. (A) A s
for enhancer activity using transfection. Random subfragments of genomic N-ca
construct a subfragment library. (B) Representative transfection data which in co
groups. Panels in the ‘‘N-cadherin’’ column show anti-N-cadherin immunostaining
reflecting enhancer activity of the inserted subfragments. Inserts of groups 1 and 2
in the lens, forebrain and retinal cultures, and group 4 inserts in the lens and for
dermal fibroblasts (not shown here). The scale bar indicates 100 Am. (C) Alignm
sequence. Green bars indicate subfragments with enhancer activity of assigned gr
used for assay. The genomic sequence is based on contigs 51.100–51.104 of Rele
in the 5V flanking region of the N-cadherin gene. However, examination of the se
the already overlapping sequences and corrected in this figure. The most distal ga
#135), which were unassigned to any of other regions, are presumed to correspoEnhancer 4 was unique in that it showed activity in
electroporated embryos only in the lens placode (after stage
14) and nasal placode (after stage 15) (Fig. 2C), without any
activity in the CNS or otic placode (data not shown), in spite
of its exhibiting enhancer activity in forebrain cells derived
from older embryos (Fig. 1B) (Table 1).
Molecular dissection of Enhancer 4
From our interest in placodal development, we first
analyzed Enhancer 4 in great detail (Fig. 3A). Inserts of
clones 22, 31 and 158 overlap in the common 2-kb span,
which is included in an EcoRI fragment, and this EcoRI
fragment had the identical enhancer activity in transfected
primary cultures (data not shown). The essential region in
the fragment was narrowed down to the AS fragment of 254
bp. As short enhancer subfragments tend to loose enhancer
strength, dimeric forms of AS subfragments were prepared
and tested for enhancer activity in the lens epithelial cells
(Fig. 3Aa). Among four overlapping subfragments of AS,
only AS3 subfragment of 87 bp showed activity, as shown
by photorecording (Fig. 3Ab) and EGFP fluorescence
measurement (Fig. 3Ac). Subfragments of AS3 were further
prepared and octamerized for assessment of enhancer
activity. The minimum element was the 30-bp AS38
fragment (Figs. 3A and B).
To characterize functional domains of the AS38 sequence
for interaction with DNA-binding proteins, a series of 3-bp
base substitutions was introduced into the sequence (Fig.
3Ba), and their effect on enhancer activity in lens cells was
examined (Fig. 3Bb). Three domains were recognized by
the effect of mutations. Block 1 corresponded to the 5V-most
9 bp, where the mutations (M1, 2 and 8) abrogated the
enhancer activity. Block 2 was the adjacent 6 bp, where
mutations (M12, 10 and 9) reduced the enhancer activity.
Block 3 was the 3V-most 4 bp, where mutations (M14 and 7)
severely reduced enhancer activity.
Nuclear factors binding to the block 1 sequence were
characterized using EMSA (Fig. 3C). As this block contains
the SOX factor-binding sequence ATTGTG (Kamachi et al.,
2000; Pevny and Lovell-Badge, 1997; Wegner, 1999) (Fig.
3Ba), and as Group B1 Sox genes are widely expressed in
the CNS and sensory placodes (Fig. 2A) (Groves andchematic illustration of screening of various N-cadherin gene subfragments
dherin locus DNA were inserted into the tkEGFP (RV) reporter vector to
mbination with mapping classified the enhancer-bearing fragments into 5
of the cultures used for transfection. Other panels show EGFP fluorescence
show enhancer activity in the forebrain and retinal cultures, group 3 inserts
ebrain cultures. Group 5 inserts showed in all cultures including lung and
ent of N-cadherin locus subfragments indicated by bars on the genomic
oups, while black bars indicate those without enhancer activity in cultures
ase 30.1f (Ensembl database), which originally had four unsequenced gaps
quence indicates that three gene-proximal gaps are due to mis-assembly of
p remains and is shown in gray. Inserts of the three clones (#12, #105 and
nd to the unsequenced region.
Fig. 2. Embryonic N-cadherin expression and the activity of N-cadherin enhancers. (A) Expression of N-cadherin, Sox2 and Sox3 in the sensory placodes and
CNS of chicken embryos at stage 12, showing similarity of their expression patterns, except that N-cadherin is also expressed in the mesodermal tissues, e.g.,
heart and somites. LP, lens placode; OP, otic placode; Br, brain; H, heart; Sm, somites. (B and C) Activity of N-cadherin enhancers in electroporated chicken
embryos. (B) Embryos in New’s culture electroporated at stage 4 with tkEGFP carrying Enhancer 2 (En-2, Clone 122) or Enhancer 3 (En-3, Clone 115) and
observed at stage 12. Br, brain; r2-5, region of rhombomeres 2–5, where En-2 activity is low; OP, otic placode, where En-2 shows significant activity; r2-6,
region of rhombomeres where En-3 is particularly high. (C) Embryos electroporated in ovo at stage 10 with tkEGFP carrying Enhancer 2 (En-2, Clone 122),
Enhancer 3 (En-3, Clone 115) or Enhancer 4 (En-4, clone 22), together with pDsRed, and observed at stage 21. DsRed fluorescence indicates the ectodermal
area of electroporation, and EGFP fluorescence indicates activity in the lens (Le) and nasal pit (NP). The En-2 and En-3 panels in this figure demonstrates lens
activity only, but other samples show activity in the nasal pit. Under visual inspection, enhancer activity in the lens placode became detectable at stage 14 and
that in the nasal placode at stage 15 (Table 2). The scale bars indicate 200 Am.
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Table 1
Enhancer activity of the clone groups in electroporated embryos and transfected cells
Clone group Clonesa Activity in electroporated embryo Activity in transfected cells
Brain, spinal cord
(stage 12)
Otic vesicle
(stage 12b)
Lens placode
(stage 14b)
Nasal placode
(stage 15b)
Lens
(E14)
Forebrain
(E7)
Retina
(E7)
Gizzard, etc.
(E10)
Group 1 17, 155, 193, 236      + + 
Group 2 23, 71, 119, 122 +c + + +  + + 
Group 3 75, 115, 215 +d  + + + + + 
Group 4 22, 31, 158   + + + +  
Group 5 35, 42, 56, 68, 121,
161, 204, 208, 239
n.d.e n.d. n.d. n.d. + + + +
a All clones were tested by transfection, and those indicated by underlines were used for electroporation as representative clones.
b Earliest stage of detection.
c Activity was high in the brain, rhombomere 1 and rhombomere 6.
d Activity was high in rhombomeres 2–6.
e Not determined.
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1998; Rex et al., 1997; Uchikawa et al., 1999, 2003;
Uwanogho et al., 1995), interaction of these SOX protein
factors with AS38-U probe DNA carrying block 1 and block
2 sequences was investigated (Fig. 3B).
When recombinant SOX1, SOX2 or SOX3 proteins of
the chicken were synthesized in COS7 cells, their nuclear
extracts were active in forming each unique bands of
probe–protein complex showing similar but slightly differ-
ent electrophoretic mobilities reflecting molecular sizes of
the SOX proteins (Kamachi et al., 1998) (Fig. 3Ca, lanes 2–
4), which was not formed by using an extract of normal
COS7 cells (Fig. 3Ca, lane 1). These complexes were
supershifted by anti-Group B1 SOX antibodies (Tanaka et
al., 2004), confirming that Group B1 SOX proteins bind
strongly to the AS38-U probe sequence (data not shown).
When a nuclear extract prepared from E14 embryonic
lenses was analyzed using EMSA, the extract produced a
group of strong bands which showed electrophoretic
mobilities corresponding to those formed with recombinant
SOX1, SOX2 and SOX3 (Fig. 3Ca, lane 5, the bands
marked by an asterisk). Indeed, anti-Group B1 SOX
antibodies supershifted all bands of this group (Fig. 3Cb,
lanes 4–5).
These Group B1 SOX–probe complexes were competed
out by excess of wild-type AS38-U sequence (Fig. 3Ca, lane
6), but this competition did not occur when the AS38-U
sequence contained the mutations M1, M2 or M8, which
alter the SOX-binding sequence (Fig. 3Ca, lanes 7–9) and
abolish enhancer activity of AS38 (Fig. 3B). By contrast,
the AS38-U sequences carrying the mutations of block 2
(M12, 10 and 9) were fully active as the competitors to the
probe (Fig. 3Ca, lanes 10–12). Finally, the complex was
efficiently competed by the known SOX-binding site
sequence (gF-SOX) of gF-crystallin promoter (Kamachi et
al., 1995) (Fig. 3Ca, lane 13). The bands which were not
competed by block 2 mutant competitors may represent
proteins binding to the blocks 2 sequence, but they have not
been characterized. Taken together, activity of the minimum
core sequence AS38 of Enhancer 4 is dependent on bindingof the Group B1 SOX proteins and two other factors binding
to blocks 2 and 3.
When the M2 mutation of block 1 was introduced in the
larger AS3 dimeric enhancer, enhancer activity was severely
compromised in transfected lens cells, with the 40-fold
activation observed using the wild-type sequence (Fig. 3Ac)
reduced to fourfold activation (data not shown). In addition,
the M2 mutation destroyed enhancer activity in the lens and
nasal placodes in electroporated head ectoderm (Fig. 5A).
These findings indicate that the binding of a SOX protein
factor to the minimum core sequence AS38 is essential to
the activation of Enhancer 4.
Analysis of Enhancer 3
Enhancer 3 is included in the shortest group 3 clone,
3453-bp insert carried by clone 115 (Fig. 4Aa). Testing
various subfragments of Enhancer 3 identified its subfrag-
ment MS of 484 bp as carrying the enhancer activity (Fig.
4Ab). Examination of the sequence of Enhancer 3 MS
fragment indicated a single candidate SOX-binding site, and
mutation of this site abrogated the enhancer activity in
transfection assay (Fig. 4Ac). When the same mutated
enhancer-bearing tkEGFP was electroporated in stage 10
head ectoderm, enhancer activity of the MS fragment in the
lens and nasal placodes was lost (Fig. 5B). Thus, the activity
of Enhancer 3 is also dependent on binding of a SOX
protein.
Analysis of Enhancer 2
Enhancer 2 is represented by the shortest group 2 clone,
3518-bp insert carried by clone 122 (Fig. 4Ba). Comparison
with the mammalian N-cadherin genomic sequence (see
Fig. 8) indicates a region with a high degree of conservation
covered by a fragment DP of 694 bp. This DP sequence
showed full enhancer activity in transfected brain cells (Fig.
4Bb) and in electroporated embryonic head ectoderm (data
not shown). The sequence contains many potential SOX-
binding sites, suggesting the multiple and possibly redun-
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the single SOX-binding sequence with a perfect match with
the consensus ATTGTG was mutated, the mutation signifi-cantly reduced the enhancer strength in transfection assay
(Fig. 4Bc), indicating that this SOX site is essential to the
enhancer activity in late brain cells. However, the same
M. Matsumata et al. / Developmental Biology 286 (2005) 601–617 609mutation only slightly attenuated the placodal enhancer
activity in electroporated embryos (Fig. 5C), suggesting that
multiple SOX-binding sites differentially regulate this
enhancer.
Sox2 and N-cadherin expression in the sensory placode
development
The analysis of Enhancers 2–4 described above indi-
cated that Group B1 SOX or related activities are involved
in the activation of N-cadherin expression. As the earliest-
expressed Sox gene in the placode development is Sox2, we
compared time course of the expression of Sox2 and N-
cadherin in the placode development. The data shown in
Fig. 6 are from representative paraffin sections of embryo
specimens hybridized in whole mount, which provide
superior signal-to-noise ratio and histology than those
hybridized after sectioning. However, the observations
described below were confirmed using the serial sections
of same embryos hybridized with different probes (data not
shown).
In development of the lens placode, Sox2 expression was
activated in the optic vesicle-contacted surface ectoderm at
stage 12, confirming the previous report (Kamachi et al.,
1998), 4 h ahead of the N-cadherin expression that initiates
at stage 13 when the placode thickens (Fig. 6A). In the nasal
placode, expression of Sox2 was initiated at stage 13, while
that of N-cadherin occurs at stage 14 (Fig. 6B). In the otic
placode, strong Sox2 expression initiated at stage 10
(concomitant with Sox3) (Fig. 2A), followed by strong N-
cadherin expression at stage 11 (Fig. 6C). N-cadherin
mRNAs were consistently localized in the apical side of
placodal cell layers, suggesting their specific subcellular
localization mechanism (Cohen, 2005; Kloc et al., 2002).
Thus, Sox2 expression always precedes that of N-cadherin
in sensory placode development, and the observations
support the model that Group B1 Sox functions are involved
in the regulation of N-cadherin expression.Fig. 3. Determination of the core region of Enhancer 4 and demonstration of SOX-
fragment of Enhancer 4 (En-4). (a) Starting from the common region of three clo
activity by transfection of lens cells. For subfragments shorter than 100 bp, the
Assessment of enhancer activity by EGFP expression, by photorecording (b), and
fragments AS1 to AS4 as an example. The scale bar in panel b indicates 100 Am.
relative to enhancer-less () tkEGFP(RV). (B) Dependence of Enhancer 4 on the
mutations introduced. Identified blocks 1–3 are indicated at the top, and the probe
binding sequence in block 1 is also indicated. (b) Effect of mutations in AS38 se
downstream of tkEGFP(RV) gene and the effect of the mutations was evaluated.
enhancer-less () tkEGFP(RV). (C) EMSA using the AS38-U probe. (a) Bindin
extracts of COS7 cells expressing Group B1 SOX proteins of the chicken (Kamac
SOX3. Lanes 5–13, analysis of chicken lens nuclear extract using various compe
AS38-U sequences carrying mutations M1, M2, M8, M12, M10 and M9, respectiv
44) (Kamachi et al., 1995). Competitors with mutations M1, M2 or M8 disrupting
the probe with Group B1 SOX proteins. The autoradiogram for lanes 5–13 was
band intensities. (b) Comparison of nuclear extracts of various embryonic tissues.
and SOX2 (lane 3) expression. Lane 4, lens (E14) nuclear extract; lane 5, lens nucl
lung fibroblast (E10) nuclear extract; lane 7, gizzard (E10) nuclear extract.Ectopic placode development by misexpression of Group B1
Sox in the head ectoderm
The analysis of Enhancers 2–4 described above indi-
cated that Group B1 SOX or related activities are indeed
involved in the activation of N-cadherin expression. As
formulated in previous studies (Kamachi et al., 2000, 2001;
Kondoh et al., 2004; Tanaka et al., 2004), Group B1 SOX
proteins function only by forming heterodimers with
specific partner factors that depend on the DNA sequence
adjacent to the SOX-binding site. Thus, it is expected that if
Group B1 Sox genes are expressed ectopically, it would
cause expression of N-cadherin, as far as relevant partner
factors are available.
Sox2 expression vector was electroporated into surface
ectoderm of stage 10 chicken embryo, when placodes are
not well developed, together with a Cytomegalovirus
enhancer-driven EGFP expression vector to visualize the
electroporated cell population (Figs. 7A and B). EGFP
fluorescence was observed 3 h after electroporation,
providing a rough estimate of the period for exogenous
gene expression after electroporation. Ectopic N-cadherin
expression became detectable in the ectoderm after 6 h of
electroporation. This time course of ectopic N-cadherin
expression is consistent with the model that N-cadherin
gene is directly activated by SOX2. On the other hand,
electroporation of the EGFP expression vector alone did not
elicit N-cadherin expression (Fig. 7C).
This N-cadherin-activating potential was common to
Group B1 Sox genes, as similar rates of ectopic N-cadherin
expression were observed using Sox1 or Sox3 expression
vectors (Table 2). By contrast, Sox genes belonging to other
groups, Sox9 (Group E), Sox11 (Group C) and Sox21
(Group B2), were inactive (Table 2), indicating Group B1-
specific action in the induction of N-cadherin expression.
It was interesting to note that the cells of head ectoderm
that received vectors for Group B1 Sox and marked by
EGFP expression not only expressed N-cadherin but alsodependent activity of the enhancer. (A) Determination of a 30-bp AS38 core
nes (#22, #31 and #158), a series of subfragments was tested for enhancer
sequences were dimerized before assessing enhancer activity. (b and c)
by fluorescence intensity measurement (c), taking comparison of the four
In panel c, relative fluorescence intensity in transfected lens cells is shown
SOX-binding site. (a) The AS38 sequence of Enhancer 4 and the series of
sequence AS38-U used for EMSA in C is shown at the bottom. The SOX-
quence on its enhancer activity. Octamerized AS38 sequences were placed
Relative fluorescence intensity in transfected lens cells is shown relative to
g of Group B1 SOX proteins to the probe sequence. Lanes 1–4, nuclear
hi et al., 1995). Lane 1, without SOX; lane 2, SOX1; lane 3, SOX2; lane 4,
titors. Lane 5, no competitor; lane 6, wild-type AS38-U; lanes 7–12, with
ely; lane 13, SOX-binding site sequence of gF-crystallin promoter (63 to
the SOX-binding sequence failed to compete out the complex formation of
taken after sevenfold longer exposure than for lanes 1–4 in order to adjust
Lanes 1–3, nuclear extracts of COS7 cells with no (lane 1), SOX1 (lane 2)
ear extract plus anti-Group B1 SOX antibodies (Tanaka et al., 2004); lane 6,
Fig. 4. Determination of the core region of Enhancers 3 and 2 by assessment of enhancer activity of various subfragments, and dependence of their activity on
SOX-binding sequences. (Aa) Determination of the core sequence of Enhancer 3 (En-3). The enhancer activity-bearing region was narrowed down to the MS
fragment of 484 bp by stepwise fragmentation. (b) Enhancer activity of various fragments in transfected forebrain cells. (c) Effect of the SOX-binding site
mutation (MS-mut) on the activity of Enhancer 3 MS fragment in transfected forebrain cells. The SOX-binding site is indicated by an oval, and original and
mutated sequences are shown. Relative EGFP fluorescence reflecting enhancer activity in transfected brain cells is shown. (Ba) Enhancer activity-bearing
fragments of Enhancer 2 (En-2). Initial overlap of group 2 clones (#119, #122, #71, #23) was roughly 4 kb. A region with a high degree of sequence
conservation found between the chicken and human genomes, represented by a DP fragment of 693 bp length (see Fig. 8), was taken as a candidate core
sequence. The DP fragment showed full enhancer activity in transfected forebrain cells (data not shown) and in lens/nasal placodes of electroporated embryos
(see Fig. 6). (b) Enhancer activity of various fragments in transfected forebrain cells. (c) Effect of mutation in one of the SOX-binding sites (DP-mut) on the
activity of Enhancer 2 DP fragment in transfected forebrain cells. Candidate SOX-binding sites are indicated by ovals.
M. Matsumata et al. / Developmental Biology 286 (2005) 601–617610gathered to form tight clusters (Fig. 7B), indicating that all
these cells expressed functional N-cadherin molecules. The
cells that received only EGFP expression vector remained
scattered in the head ectoderm.In the head ectoderm electroporated with Group B1 Sox
genes and labeled with EGFP expression (Figs. 7E and H),
expression of N-cadherin proteins was confirmed using a
monoclonal antibody (Fig. 7F), and in addition thickening
Fig. 5. Activity of subfragments of Enhancers 4, 3 and 2 in the lens placode in electroporated embryos. Stage 10 embryos were electroporated in ovo in
the head surface ectoderm in the area of forming lens placode, and enhancer activity at stage 21 was photorecorded. Electroporated areas are marked by
DsRed fluorescence, and enhancer activity is indicated by EGFP fluorescence. Arrows point to the ventral aspect of lenses. The numbers to the right of
the panels indicate enhancer active samples in lens (Le) and nasal pit (NP) among successfully electroporated samples. (A) AS3 fragment and its M2
mutant version (Fig. 3) of Enhancer 4 (En-4) in dimeric form. The mutation inactivated the enhancer in the lens. (B) MS fragment of Enhancer 3 (En-3)
and its SOX site mutant MS-mut (Fig. 4Ac). The mutation inactivated the enhancer in the lens. (C) DP fragment of Enhancer 2 and its mutant version
(Fig. 4Bc). Although the mutation inactivated the enhancer in transfected forebrain cells (Fig. 4Bc), it only slightly decreased the enhancer activity in the
lens. The scale bar indicates 10 Am.
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(Fig. 7I) characteristic of sensory placodes were observed.
These observations indicate that Group B1 Sox not only
activates N-cadherin expression in the cells but also directs
a series of molecular events which lead to the establishment
of the placodes.
An interesting observation was that ectopic N-cadherin
expression occurred efficiently when electroporation of the
Group B1 Sox expression vectors was targeted to head
ectoderm, but that efficiency was significantly lower when
electroporation was done on the trunk ectoderm (Table 2).
This probably indicates that the major partner factors ofGroup B1 SOX for the activation of N-cadherin enhancers
are available only in the head ectoderm.Discussion
Systematic screening for N-cadherin enhancers
In this study, we took a systematic approach in iden-
tifying enhancers regulating the N-cadherin gene, evenly
scanning the entire N-cadherin locus using a BAC subfrag-
ment plasmid library constructed in a tk-EGFP expression
Fig. 6. Expression of Sox2 and N-cadherin in the sensory placodes and CNS of chicken embryos. Cross sections of embryos at the initial stages of placode
development are shown. (A) Lens placode at stages 12 and 13. (B) Nasal placode at stages 13 and 14. (C) Otic placode at stages 10 and 11. Paraffin sections
were made after whole mount in situ hybridization. Hybridization of serial frozen section yielded similar results (data not shown), but for better signal-to-noise
ratio and histology, these sections are shown. The arrowheads in black indicate expression of the gene, while those in white indicate low expression. Expression
of Sox2 precedes that of N-cadherin. The scale bars indicate 50 Am.
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specific cells and electroporation of chicken embryos using
the same plasmids. An earlier view held that regulatory
sequences (enhancers) are localized in the vicinity of the
promoter. However, cumulative evidence indicates that
enhancers are widespread around the gene, as exemplified
by our previous study of Sox2 enhancers (Uchikawa et al.,
2003, 2004). Many enhancers are utilized differentially in
the spatiotemporal order, responding to diverse signals and
different sets of transcription factors, but the functions of
these enhancers are organized to satisfy consistent expres-
sion of a gene in a tissue. In the present study, the N-cadherin
gene was also shown to harbor discrete enhancers active in
the CNS and placodal development.
It is a generally accepted notion that a substantial fraction
of candidate regulatory sequences is predictable as con-
served sequences across the phyla. Our previous study on
widely scattered Sox2 enhancers determined by functional
assay indicated that such regulatory sequences in amniotes
are predictable with reasonable accuracy as the sequence
blocks highly conserved between mammalian and chicken
genomes (Uchikawa et al., 2003). This empirical rule
appears to hold true for N-cadherin enhancers (Fig. 8,
green stripes), as Enhancers 1, 2 and 4 match a subset of
conserved sequence blocks, other than exons (Fig. 8, blue
stripes), found between the chicken and human N-cadherin
sequences. Comparison of the chicken and human N-cadherin genomic sequences also indicates there are six
more blocks clearly conserved between the chicken and
human, three in intron 2 (Fig. 8, pink stripes). It is likely that
these represent regulatory sequences for mesodermal N-
cadherin regulation (Hatta and Takeichi, 1986; Hatta et al.,
1987) (Fig. 2A), which were not investigated in this study.
When human and mouse sequences were compared those
sequence blocks conserved between the chicken and human
N-cadherin genes are obscured by being buried within
longer stretches of sequence similarity, as we experienced
with the Sox2 enhancers (Uchikawa et al., 2003). These
findings confirm the significance of the conserved sequence
blocks common to chicken and mammalian genes.
However, the present study also raises a warning on the
approach of relying solely on sequence conservation. As
exemplified by neuro-placodal Enhancer 3 and non-
specific Enhancer 5 of chicken N-cadherin, which were
not found in mammalian N-cadherin locus (Fig. 8),
enhancers exist that may be unique to a branch of
phylogenic development.
A reliable way to determine regulatory sequences may be
to systematically test various genomic regions, and then to
identify the foci of important sequences with the aid of
sequence conservation across animal species, as carried out
in the analysis of Enhancer 2. In any event, the approach
taken here, namely, to construct a random fragment library
of a BAC insert in a reporter vector, and then to assess
Fig. 7. Ectopic induction of N-cadherin expression and placode development by in ovo electroporation of chicken embryo with Sox2 expression vector.
Embryos at stage 10 were electroporated with Sox2 expression vector (pCMV/SV1-Sox2; Kamachi et al., 1999) or insert-free vector at 5 Ag/Al, and 1 Ag/Al
EGFP expression vector in the region of the surface ectoderm caudal to the eye. Analysis was done at stage 21. (A) An embryo electroporated with Sox2
expression vector and hybridized in whole mount with N-cadherin probe. Strong N-cadherin expression is observed in the region of the electroporation of
the surface ectoderm. (B) EGFP fluorescence of the same embryo showing the region of electroporation. The region boxed in panel A is shown. Note that
EGFP-positive cells form coherent clusters. (C and D) An embryo analogous to panels A and B but without the Sox2 expression vector in which no ectopic
expression of N-cadherin occurs (C). Note also that electroporated EGFP-expressing cells remain scattered (D). (E–J) Embryos electroporated analogous to
panel A at stage 23 were cut into serial frozen sections (E–G and H–J) and immunohistologically analyzed: (E and H) EGFP immunofluorescence; (F) N-
cadherin immunofluorescence and (I) N-CAM immunofluorescence; and (G and J) differential interference contrast (DIC) images of the sections. The cluster
of electroporated cells marked by EGFP expression (E and H, arrowheads) becomes thickened columnar epithelium and assumes placodal morphology (G
and J) and express N-cadherin (F) and N-CAM (I). NR, neural retina; Le, lens. The scale bars in panels A–D indicate 100 Am, and those in panels E and H
50 Am.
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poration, is highly efficient. Analogous approaches should
be taken in the investigation of various genes of devel-
opmental interest to gain a precise view of how the gene is
regulated.Among the five N-cadherin enhancers identified in this
study, Enhancer 1 is located in the intron 1-exon 2 region,
and broadly active Enhancers 2 and 3 are located in the long
intron 2, while Enhancer 4 is in intron 13 and Enhancer 5
is downstream of the gene. Recent investigation of mouse
Table 2
Frequency of ectopic N-cadherin expression observed after electroporation
of Sox expression vectors (Kamachi et al., 1999; Uchikawa et al., 1999) in
the ectoderm of stage 10 embryos
Ectodermal region Head Trunk
N-cadherin expression  +/ +  +/ +
Sox2 2 Ag/Al 1/12 12/13
5 Ag/Al 8/8 3/6 3/6
Sox1 2 Ag/Al 1/14 13/14
5 Ag/Al 6/6 4/5 1/5
Sox3 2 Ag/Al 1/5 1/5 3/5
5 Ag/Al 5/5
Sox21 5 Ag/Al 2/2
Sox9 2 Ag/Al 4/4
5 Ag/Al 3/3
Sox11 2 Ag/Al 2/2
5 Ag/Al 4/4
Non-Sox DNA 2 Ag/Al 4/4
5 Ag/Al 2/2
DNAs at different concentrations were delivered on embryos and electro-
porated. Embryos were fixed at 18, 24 and 36 h after electroporation for
examination of N-cadherin expression by whole mount in situ hybrid-
ization. Since data of the three stages are consistent, they are compiled to
give the table: , No ectopic N-cadherin expression; +/, N-cadherin
expression at the marginal level of detection; +, definite N-cadherin
expression as seen in Fig. 7A. The number of cases in each experimental
group is indicated.
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indicates that the major regulatory elements are included
in intron 2, while E-cadherin expression in some specific
tissues (e.g., yolk sac and apical ectodermal ridge) are
independent of the intron 2 sequence. This characteristic of
widely scattered enhancer elements through the gene locus
may be common to cadherin genes.
Differential spatiotemporal regulation of N-cadherin
enhancers
The observations made in this study clearly indicate that
N-cadherin expression is temporally regulated by reliance
on discrete, stage-dependent activity of the enhancers (Table
1). In transfection assay, Enhancer 1 was active in the
forebrain and retinal cells, but the same enhancer showed no
activity in the electroporated early embryos, suggesting that
Enhancer 1 regulates N-cadherin gene in later development
of the CNS. Enhancer 2 was active in the forebrain and
retina cells in transfection assay without activity in the lens
epithelium, but in electroporated embryos this enhancer
showed prominent activity not only in the CNS, but also in
all nasal, lens and otic placodes. Thus, Enhancer 2 regulates
N-cadherin in the early placodes, and in the early to late
CNS. Analogously, Enhancer 4 was active both in the lens
epithelial and forebrain cultures but showed no activity in
the early embryonic CNS, indicating that it also functions
late in the CNS. It was also noted that although Enhancers 2
and 3 were active throughout the early CNS, there were
regional differences in their activity, particularly in the
rhombomere region (Fig. 2B).It is also to be noted that while Enhancer 2 is active in all
three sensory placodes, Enhancers 3 and 4 are active only in
nasal and lens placodes (Fig. 2C). It is known that sensory
placode precursors are derived from a similar, anterior
embryonic location as indicated by cell tracing analysis, and
are interchangeable to a certain extent, as indicated by
experiments using heterotopic and heteroplastic grafts of
embryonic ectoderm, and that the unique developmental fate
of individual placodes appears to be determined by local
inductive cues originated from surrounding tissue (Baker
and Bronner-Fraser, 2001; Bhattacharyya et al., 2004; Streit,
2004; Vogel and Davies, 1993; Webb, 1993). It is possible
that Enhancer 2 is activated by a mechanism pertinent to
global placode development, while the activation of
enhancers 3 and 4 is linked to lens and nasal specificity.
This study also demonstrated that early neural/placodal
Enhancers 2–4 are all dependent on a SOX-binding site,
where Group B1 SOX proteins, exemplified by SOX2,
likely act. It is important to note that Group B1 SOX
proteins do not function by themselves, but act by forming
complexes with a partner factor binding to a DNA sequence
in proximity of the SOX site (Kamachi et al., 2000, 2001;
Kondoh et al., 2004; Tanaka et al., 2004). It is possible that
availability of the SOX partner factors that depend on the
enhancers limits the activity to certain developmental stages
and to subsets of neuro-placodal tissues. Availability of the
SOX partner factors for activation of placodal enhancers
may also delimit placodal development to the cephalic
region, as induction of ectopic placodes by exogenous
Group B1 Sox genes occurs only in the corresponding
region of the embryos (Table 2). Identification of these
partner factors and investigation of their regulation would
clarify how the specificity of these enhancers is determined.
Not only SOX2 protein regulates N-cadherin Enhancers
2–4 active in the sensory placodes, but Group B1 Sox genes
themselves are also under placode-specific regulation. Our
previous study (Uchikawa et al., 2003) has shown that Sox2
expression in the nasal and otic placodes is regulated by the
same enhancers, namely, NOP-1 and NOP-2, while lens
placodal Sox2 expression is regulated by enhancer N-3. This
different coverage of enhancers for sensory placodes
between the N-cadherin and Sox2 genes must reflect a
multitude of gene regulation in placode development.
Further analysis of these placodal enhancers for interacting
partner factors and upstream signaling systems would be
highly informative in understanding the development of the
common placodal nature, as well as the individual character-
istics of the sensory placodes.
Involvement of Group B1 Sox functions in neuro-placodal
development
The essential involvement of Group B1 Sox functions in
N-cadherin expression and neuro-placodal development
gained a strong support from expression analysis and was
confirmed by Sox misexpression experiments.
Fig. 8. Analysis of sequences conserved between chicken and mammalian N-cadherin genes using the VISTA program. Upper rows: Comparison of chicken
versus human N-cadherin sequence, evaluating every 50 bp alignment and plotting regions over 45% sequence identity. The abscissa represents human
sequence coordinates. Exons are indicated by blue stripes, enhancers identified in this study by green stripes, and other highly conserved region found between
the human and chicken sequence by pink stripes. Lower rows, comparison of mouse and human N-cadherin genomic sequences based on the same criteria.
Conservation of Enhancer 4 sequence between human and chicken is less pronounced compared with Enhancers 1, 2 or 5, but significance of conservation is
highlighted by remarkably high score of this region between human and mouse. Enhancers 3 and 5 sequences determined in the chicken genome does not have
a corresponding sequence in mammalian genomes and are positioned roughly in the way to reflect their coordinates in the chicken sequence. Note three pink-
shaded prominent peaks in intron 2, which may correspond to mesodermal enhancers or sensory/neural enhancers of later development.
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both marked by expression of Sox2, or Sox2 plus Sox3, in
the chicken and mouse embryos (Rex et al., 1997;
Uchikawa et al., 2003; Uwanogho et al., 1995; Wood and
Episkopou, 1999). During neural plate development, high
N-cadherin expression is then activated and a dramatic
change in tissue architecture involving thickening of the cell
sheet (neural plate) is initiated (Hatta and Takeichi, 1986;
Hatta et al., 1987; Takeichi, 1988). In the present study, it
was clearly shown that N-cadherin expression and thicken-
ing of placodal cell sheet occur synchronously in three
sensory placodes and are preceded by Sox2 expression
(Fig. 6).
Misexpression of Group B1 Sox genes in the head
ectoderm of stage 10 chicken embryo caused ectopic
development of placodal structures (Fig. 7, Table 2), where
not only was N-cadherin expression activated, but cell
clustering, cell sheet thickening and N-CAM expression
also took place. N-cadherin gene activation is thus a
prominent example of the many processes of placodal
development that are under the regulation of Group B1 Sox
activity.
Involvement of Group B1 Sox function was suggested by
an earlier study (Koster et al., 2000), in which over-
expression of exogenous Sox3 in whole Medaka embryo
caused frequent development of ectopic lenses and otic
vesicles, but due to complex interactions in the process, a
cell-autonomous effect of exogenous Sox3 was not always
demonstrated. The present study, however, demonstrated
that ectopic placodes develop as a direct consequence of
misexpression of Group B1 Sox genes in the head ectoderm.
Many genes involved in placodal development are thus
expected to bear multiple SOX-dependent enhancers, as
was determined in the N-cadherin gene. These multiple
enhancers may function in concert to provide the general
placodal nature, and variability of the SOX partner
factors will determine the characteristics of individual
placodes or specific domains of the CNS. Although the
N-cadherin gene is just one example case, further
characterization of the enhancers determined in this study
should provide deep insight into the process of neuro-
placodal development.Acknowledgments
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